Literature DB >> 19183708

ANALYSIS OF HEPATITIS C VIRUS INFECTION MODELS WITH HEPATOCYTE HOMEOSTASIS.

Timothy C Reluga1, Harel Dahari, Alan S Perelson.   

Abstract

Recently, we developed a model for hepatitis C virus (HCV) infection that explicitly includes proliferation of infected and uninfected hepatocytes. The model predictions agree with a large body of experimental observations on the kinetics of HCV RNA change during acute infection, under antiviral therapy, and after the cessation of therapy. Here we mathematically analyze and characterize both the steady state and dynamical behavior of this model. The analyses presented here are important not only for HCV infection but should also be relevant for modeling other infections with hepatotropic viruses, such as hepatitis B virus.

Entities:  

Year:  2009        PMID: 19183708      PMCID: PMC2633176          DOI: 10.1137/080714579

Source DB:  PubMed          Journal:  SIAM J Appl Math        ISSN: 0036-1399            Impact factor:   2.080


  44 in total

Review 1.  Modelling viral and immune system dynamics.

Authors:  Alan S Perelson
Journal:  Nat Rev Immunol       Date:  2002-01       Impact factor: 53.106

2.  Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees.

Authors:  Marian E Major; Harel Dahari; Kathleen Mihalik; Montserrat Puig; Charles M Rice; Avidan U Neumann; Stephen M Feinstone
Journal:  Hepatology       Date:  2004-06       Impact factor: 17.425

3.  Hepatitis B viral kinetics: a dynamic puzzle still to be resolved.

Authors:  Avidan U Neumann
Journal:  Hepatology       Date:  2005-08       Impact factor: 17.425

4.  HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.

Authors:  A S Perelson; A U Neumann; M Markowitz; J M Leonard; D D Ho
Journal:  Science       Date:  1996-03-15       Impact factor: 47.728

5.  Second hepatitis C replication compartment indicated by viral dynamics during liver transplantation.

Authors:  Harel Dahari; Anna Feliu; Montserrat Garcia-Retortillo; Xavier Forns; Avidan U Neumann
Journal:  J Hepatol       Date:  2005-01-13       Impact factor: 25.083

6.  Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors:  M P Manns; J G McHutchison; S C Gordon; V K Rustgi; M Shiffman; R Reindollar; Z D Goodman; K Koury; M Ling; J K Albrecht
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

7.  Dynamics of alanine aminotransferase during hepatitis C virus treatment.

Authors:  Ruy M Ribeiro; Jennifer Layden-Almer; Kimberly A Powers; Thomas J Layden; Alan S Perelson
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

Review 8.  Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins.

Authors:  Stefan Duensing; Karl Münger
Journal:  Int J Cancer       Date:  2004-03-20       Impact factor: 7.396

9.  Interferon modulation of cellular microRNAs as an antiviral mechanism.

Authors:  Irene M Pedersen; Guofeng Cheng; Stefan Wieland; Stefano Volinia; Carlo M Croce; Francis V Chisari; Michael David
Journal:  Nature       Date:  2007-10-18       Impact factor: 49.962

10.  Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein.

Authors:  Chih-Fei Kao; Shiow-Yi Chen; Jeou-Yuan Chen; Yan-Hwa Wu Lee
Journal:  Oncogene       Date:  2004-04-01       Impact factor: 9.867

View more
  15 in total

Review 1.  A perspective on modelling hepatitis C virus infection.

Authors:  J Guedj; L Rong; H Dahari; A S Perelson
Journal:  J Viral Hepat       Date:  2010-08-15       Impact factor: 3.728

Review 2.  A New Model for the Dynamics of Hepatitis C Infection: Derivation, Analysis and Implications.

Authors:  Philip J Aston
Journal:  Viruses       Date:  2018-04-13       Impact factor: 5.048

3.  Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and IL28B.

Authors:  Harel Dahari; Jeremie Guedj; Alan S Perelson; Thomas J Layden
Journal:  Curr Hepat Rep       Date:  2011-07-02

Review 4.  Modelling hepatitis C therapy--predicting effects of treatment.

Authors:  Alan S Perelson; Jeremie Guedj
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-30       Impact factor: 46.802

5.  Modeling quasispecies and drug resistance in hepatitis C patients treated with a protease inhibitor.

Authors:  Libin Rong; Ruy M Ribeiro; Alan S Perelson
Journal:  Bull Math Biol       Date:  2012-05-26       Impact factor: 1.758

6.  ModeLang: a new approach for experts-friendly viral infections modeling.

Authors:  Szymon Wasik; Tomasz Prejzendanc; Jacek Blazewicz
Journal:  Comput Math Methods Med       Date:  2013-12-18       Impact factor: 2.238

7.  Controlling of pandemic COVID-19 using optimal control theory.

Authors:  Shahriar Seddighi Chaharborj; Sarkhosh Seddighi Chaharborj; Jalal Hassanzadeh Asl; Pei See Phang
Journal:  Results Phys       Date:  2021-05-19       Impact factor: 4.476

8.  Analysis of the virus dynamics model reveals that early treatment of HCV infection may lead to the sustained virological response.

Authors:  Saurabh Gupta; Raghvendra Singh
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

9.  Ebola virus infection modeling and identifiability problems.

Authors:  Van Kinh Nguyen; Sebastian C Binder; Alessandro Boianelli; Michael Meyer-Hermann; Esteban A Hernandez-Vargas
Journal:  Front Microbiol       Date:  2015-04-09       Impact factor: 5.640

10.  The Role of Infected Cell Proliferation in the Clearance of Acute HBV Infection in Humans.

Authors:  Ashish Goyal; Ruy M Ribeiro; Alan S Perelson
Journal:  Viruses       Date:  2017-11-18       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.